This HTML5 document contains 70 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n7http://linked.opendata.cz/resource/domain/vavai/subjekt/
n6http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00023001%3A_____%2F11%3A00002544%21RIV12-MZ0-00023001/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n15http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00023001%3A_____%2F11%3A00002544%21RIV12-MZ0-00023001
rdf:type
n6:Vysledek skos:Concept
dcterms:description
Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country-specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel. Data references were identified through indexed journals and non-indexed sources. In this work, 13 000 articles were reviewed and 860 were selected based on their relevance. Differences in prevalence were explained by local and regional variances in transmission routes or different public health measures. The lowest HCV prevalence (<=0.5%) estimates were from northern European countries and the highest (>=3%) were from Romania and rural areas in Greece, Italy and Russia. The main risk for HCV transmission in countries with well-established HCV screening programmes and lower HCV prevalence was injection drug use, which was associated with younger age at the time of infection and a higher infection rate among males. In other regions, contaminated glass syringes and nosocomial infections continue to play an important role in new infections. Immigration from endemic countries was another factor impacting the total number of infections and the genotype distribution. Approximately 70% of cases in Israel, 37% in Germany and 33% in Switzerland were not born in the country. In summary, HCV epidemiology shows a high variability across Europe, Canada and Israel. Despite the eradication of transmission by blood products, HCV infection continues to be one of the leading blood-borne infections in the region. Decisions on public health issues are dependent on reliable epidemiological data. A comprehensive review of the literature was used to gather country-specific data on risk factors, prevalence, number of diagnosed individuals and genotype distribution of the hepatitis C virus (HCV) infection in selected European countries, Canada and Israel. Data references were identified through indexed journals and non-indexed sources. In this work, 13 000 articles were reviewed and 860 were selected based on their relevance. Differences in prevalence were explained by local and regional variances in transmission routes or different public health measures. The lowest HCV prevalence (<=0.5%) estimates were from northern European countries and the highest (>=3%) were from Romania and rural areas in Greece, Italy and Russia. The main risk for HCV transmission in countries with well-established HCV screening programmes and lower HCV prevalence was injection drug use, which was associated with younger age at the time of infection and a higher infection rate among males. In other regions, contaminated glass syringes and nosocomial infections continue to play an important role in new infections. Immigration from endemic countries was another factor impacting the total number of infections and the genotype distribution. Approximately 70% of cases in Israel, 37% in Germany and 33% in Switzerland were not born in the country. In summary, HCV epidemiology shows a high variability across Europe, Canada and Israel. Despite the eradication of transmission by blood products, HCV infection continues to be one of the leading blood-borne infections in the region.
dcterms:title
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
skos:prefLabel
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
skos:notation
RIV/00023001:_____/11:00002544!RIV12-MZ0-00023001
n6:predkladatel
n7:ico%3A00023001
n4:aktivita
n8:N
n4:aktivity
N
n4:cisloPeriodika
suppl.
n4:dodaniDat
n15:2012
n4:domaciTvurceVysledku
n13:8257809
n4:druhVysledku
n11:J
n4:duvernostUdaju
n14:S
n4:entitaPredkladatele
n12:predkladatel
n4:idSjednocenehoVysledku
184209
n4:idVysledku
RIV/00023001:_____/11:00002544
n4:jazykVysledku
n17:eng
n4:klicovaSlova
epidemiology; HCV; hepatitis C; incidence; mortality; prevalence
n4:klicoveSlovo
n5:hepatitis%20C n5:epidemiology n5:prevalence n5:HCV n5:incidence n5:mortality
n4:kodStatuVydavatele
US - Spojené státy americké
n4:kontrolniKodProRIV
[29B5CB534956]
n4:nazevZdroje
Liver international
n4:obor
n16:FE
n4:pocetDomacichTvurcuVysledku
1
n4:pocetTvurcuVysledku
32
n4:rokUplatneniVysledku
n15:2011
n4:svazekPeriodika
31
n4:tvurceVysledku
Bernasconi, E. Young, K. Yurdaydin, C. Pol, S. Zuckerman, E. Puoti, M. M. Largen, A. Hunyady, B. Negro, E. Zeuzem, S. Dillion, JF Buti, M. Dalgard, O. Lagging, M. Cooper, C. Halota, W. Wallace, C. Cornberg, M. Marcellin, P. Makara, M. Flisiak, R. Forns, X. Manolakopoulos, S. Simon, K. Sagalova, O. Alberti, A. Goulis, I. Sibbel, S. Fraňková, Soňa Razavi, HA Poynard, T. Marinho, RT
s:issn
1478-3223
s:numberOfPages
31